Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches Mannosylated liposomes for oral drug delivery Pongthep Pukanud et al.

Drug Delivery

Volumn 16, Issue 5, 2009, Pages 289-294

  Pukanud, Pongthep ^a   Peungvicha, Penchom ^a   Sarisuta, Narong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acyclovir; Bioadhesive carriers; Everted sac method everted sac method; Mannosylated liposomes; Peyer's patch

Indexed keywords

4 AMINOPHENYL ALPHA DEXTRO MANNOPYRANOSIDE; ACICLOVIR; DRUG CARRIER; LIPOSOME; MANNOSAMINE; PHOSPHOLIPID; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEXOSAMINE; MANNOSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILAYER MEMBRANE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ILEUM; IN VITRO STUDY; INTESTINE ABSORPTION; INTESTINE CELL; MALE; MEMBRANOUS EPITHELIAL CELL; MOUSE; NONHUMAN; PARTICLE SIZE; PEYER PATCH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACEUTICS;

ACYCLOVIR; ADMINISTRATION, ORAL; ANIMALS; ANTI-HIV AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEXOSAMINES; LIPOSOMES; MANNOSE; MICE; PARTICLE SIZE; PEYER'S PATCHES; TECHNOLOGY, PHARMACEUTICAL;

EID: 70349319399     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540902989738     Document Type: Article

References (17)

1. Aramaki, Y., Tomizawa, H., Hara, T., Yachi, K., Kikuchi, H., Tsuchiya, S. (1993). Stability of liposomes in vitro their uptake by rat Peyer's patches following oral administration. Pharm Res. 10, 1228-1231 (Pubitemid 23244182)
2. Beutner, K.R. (1995). Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res. 28, 281-290
3. Borges, O., Borchard, G., Verhoef, J.C., Sousa, A.D., Junginger, H.E. (2005). Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm. 299, 155-166
4. Clark, M.A., Jepson, M.A., Hirst, B.H. (2001). Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev. 50, 81-106.
5. Clark, M.A., Blair, H., Liang, L., Brey, R.N., Brayden, D., Hirst, B.H. (2002). Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccines. 20, 208-217
6. Ermak, T., Giannasca, P.J. (1998). Microparticle targeting to M cells. Adv Drug Deliv Rev. 34, 261-283
7. Ghosh, P.K., Majithiya, R.J., Umrethia, M.L., Murthy, R.S. (2006). Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS Pharm Sci Tech. 7, 1-6.
8. Jepson, M.A., Clark, M.A., Hirst, B.H. (2004). M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. Adv Drug Deliv Rev. 56, 511-525
9. Kreuter, J. (1991). Peroral administration of nanoparticles. Adv Drug Deliv Rev. 7, 71-86.
10. McEvoy, G.K. (2005). AHFS Drugs Information, American Society of Health System Pharmacists. Bethesda, MD: Atlantic Books.
11. O'Brien, J.J., Campoli-Richards, D.M. (1989). Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 37, 233-309.
12. Pringault, E. (1999). Emerging concepts in M cell function and Peyer's patch development. Immunology. 11, 155-156
13. Wagner, S., Lynch, N.J., Walter, W., Schwaeble, W.J., Loos, M. (2003). Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol. 170, 1462-1465
14. White, K.L., Rades, T., Furneaux, R.H., Tyler, P.C., Hook, S. (2006). Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells. J Pharm Pharmacol. 58, 729-737
15. Woodley, J. (2001). Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet. 40, 77-84.
16. Young, B., Heath, J.W. (2000). Wheater's functional histology. 4th ed. London: Churchill Livingstone.
17. Zhang, N., Ping, Q.N., Huang, G.H., Xu, W.F. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm. 294, 247-259